FDA cleared the GMK Extension from Medacta International SA on Sep 15, 2026 under K262057, a traditional 510(k). The device falls under product code JWH, Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, regulated at 21 CFR 888.3560 as a Class 2 device. The review panel was Orthopedic.
FDA logged the submission as received on Jun 18, 2026. The decision came 89 days later, inside the 90 FDA-day goal for a 510(k).
Medacta International SA has 8 other decisions in the tracker over the last 12 months: K260173 (M-Vizion Femoral Revision System Extension), K253630 (Mpact 3D Metal Foam), K261016 (MSS - Humeral reverse liners extension), K254202 (MectaLIF 3D Metal Anterior).